Monday, March 1, 2021

Repurposed arthritis drug did not significantly improve severe COVID-19 pneumonia

A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo, according to a new study.

from Top Health News -- ScienceDaily https://ift.tt/2NQgYE1
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

11,000-year-old feast uncovered: Why hunters hauled wild boars across mountains

Ancient Iranians hosted epic feasts with wild boars that had been hunted and transported from distant regions. These animals weren’t just di...